University of Miami, Phillip Frost Dermatology Clinic
Miami, Florida, 33136, United States
NCT Number: NCT07820969
The purpose of this study is to directly compare the efficacy of suzetrigine vs. oxycodone+acetaminophen vs. alternating acetaminophen/ibuprofen in controlling post-operative pain after the following nail unit procedures.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Phase 4
Miami, Florida, 33136, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will receive two 50 mg oral tablets on day 1, followed by 50 mg oral tablets every 12 hours for 5 days
Participants will receive Oxycodone + acetaminophen combination administered orally at a dose of 50 mg/325 mg per tablet, every 6 hours for 5 days starting the day of the nail procedure
Participants will receive Acetaminophen administered orally at a dose of 650 mg every 6 hours for 5 days starting the day of the nail procedure. Alternate with ibuprofen 400 mg every 6 hours for 5 days starting day of nail procedure
Time frame: 24 hours post nail procedure, 48 hours post nail procedure, 72 hours post nail procedure
Pot-operative pain intensity measured using the Numeric Rating Scale (NRS, 0-10), where 0 indicates no pain and 10 indicates worst possible pain; higher scores indicate greater pain following nail unit procedures.
Trial opening soon.
Get NotifiedUniversity of Miami
Other
Post-operative Analgesia of Nail Unit Procedures: A Prospective Pilot Study Comparing Suzetrigine vs. Oxycodone+Acetaminophen vs. Acetaminophen/Ibuprofen
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04941807
Nail Diseases, Skin Diseases
New York, United States
View Trial DetailsNCT03991936
Nail Diseases, Nail Psoriasis
New York, United States
View Trial DetailsNCT05544734
Agnosia, Nail Abnormality
New York, United States
View Trial DetailsNCT00925418
Breast Diseases, Breast Neoplasms
Marseille, France
View Trial Details